TDP-43 subtypes are associated with distinct atrophy patterns in frontotemporal dementia

Neurology

Volumn 75, Issue 24, 2010, Pages 2204-2211

  Rohrer, J D ^a   Geser, F ^c   Zhou, J ^b   Gennatas, E D ^b   Sidhu, M ^b   Trojanowski, J Q ^c   Dearmond, S J ^b   Miller, B L ^b   Seeley, W W ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Center for Neurodegenerative Disease Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TAR DNA BINDING PROTEIN;

ADULT; AGED; ARTICLE; BRAIN ATROPHY; BRAIN DEGENERATION; CLINICAL ARTICLE; CLINICAL FEATURE; COGNITION; CONTROLLED STUDY; CORPUS STRIATUM; DISEASE ASSOCIATION; FEMALE; FRONTAL LOBE; FRONTAL VARIANT FRONTOTEMPORAL DEMENTIA; FRONTOTEMPORAL DEMENTIA; GRAY MATTER; HUMAN; IMAGE ANALYSIS; IMMUNOREACTIVITY; MALE; MIDDLE TEMPORAL GYRUS; MOTOR NEUROPATHY; NEUROIMAGING; NEUROPSYCHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; ORBITAL CORTEX; PARIETAL CORTEX; PRIORITY JOURNAL; PROGRESSIVE NONFLUENT APHASIA; SEMANTIC DEMENTIA; TDP 43 PROTEINOPATHY; TEMPORAL LOBE; THALAMUS; VOXEL BASED MORPHOMETRY;

AGED; AGED, 80 AND OVER; APHASIA; ATROPHY; BRAIN; DNA-BINDING PROTEINS; FEMALE; FRONTAL LOBE; FRONTOTEMPORAL DEMENTIA; FRONTOTEMPORAL LOBAR DEGENERATION; HUMANS; INCLUSION BODIES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; TEMPORAL LOBE; THALAMUS;

EID: 78650843210     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e318202038c     Document Type: Article

References (34)

1. Mackenzie IR, Neumann M, Bigio EH, et al. Nomenclature and nosology for neuropathologic subtypes of fronto-temporal lobar degeneration: an update. Acta Neuropathol 2010;119:1-4.
2. Snowden J, Neary D, Mann D. Frontotemporal lobar degeneration: clinical and pathological relationships. Acta Neuropathol 2007;114:31-38. (Pubitemid 47029057)
3. Dickson DW. Neuropathologic differentiation of progressive supranuclear palsy and corticobasal degeneration. J Neurol 1999;246(suppl 2):II6-II15.
4. Sampathu DM, Neumann M, Kwong LK, et al. Pathological heterogeneity of frontotemporal lobar degeneration with ubiquitin-positive inclusions delineated by ubiquitin immunohistochemistry and novel monoclonal antibodies. Am J Pathol 2006;169:1343-1352.
5. Mackenzie IR, Baborie A, Pickering-Brown S, et al. Heterogeneity of ubiquitin pathology in frontotemporal lobar degeneration: classification and relation to clinical pheno-type. Acta Neuropathol 2006;112:539-549.
6. Forman MS, Trojanowski JQ, Lee VM. TDP-43: a novel neurodegenerative proteinopathy. Curr Opin Neurobiol 2007;17:548-555.
7. Geser F, Lee VM, Trojanowski JQ. Amyotrophic lateral sclerosis and frontotemporal lobar degeneration: a spectrum of TDP-43 proteinopathies. Neuropathology Epub 2010 Jan 25.
8. Van Deerlin VM, Wood EM, Moore P, et al. Clinical, genetic, and pathologic characteristics of patients with frontotemporal dementia and progranulin mutations. Arch Neurol 2007;64:1148-1153.
9. Grossman M, Wood EM, Moore P, et al. TDP-43 pathologic lesions and clinical phenotype in frontotemporal lo-bar degeneration with ubiquitin-positive inclusions. Arch Neurol 2007;64:1449-1454.
10. Beck J, Rohrer JD, Campbell T, et al. A distinct clinical, neuropsychological and radiological phenotype is associated with progranulin gene mutations in a large UK series. Brain 2008;131:706-720.
11. Folstein M, Folstein S, McHugh P. The "Mini Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
12. Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 1993;43:2412-2414.
13. Kaplan EF, Goodglass H, Weintraub S. The Boston Naming Test. Philadelphia: Lea & Febiger; 1983.
14. Delis DC, Kramer JH, Kaplan E, Ober BA. California Verbal Learning Test, 2nd ed. San Antonio, TX: The Psychological Corporation; 2000.
15. Osterrieth PA. Le test de copie d'une figure complexe: contribution a l'eìtude de la perception et de la me ìmoire. Arch Psychol 1944;30:206-256.
16. Reitan RM. Validity of the Trailmaking Test as an indication of organic brain damage. Percept Mot Skills 1958;8: 271-276.
17. Delis DC, Kaplan E, Kramer JH. The Delis-Kaplan Executive Function System. San Antonio: The Psychological Corporation; 2001.
18. Rohrer JD, Ridgway GR, Crutch SJ, et al. Progressive logopenic/ phonological aphasia: erosion of the language network. Neuroimage 2010;49:984-993.
19. Tartaglia MC, Sidhu M, Laluz V, et al. Sporadic cortico-basal syndrome due to FTLD-TDP. Acta Neuropathol 2010;119:365-374.
20. Rabinovici GD, Seeley WW, Kim EJ, et al. Distinct MRI atrophy patterns in autopsy-proven Alzheimer's disease and frontotemporal lobar degeneration. Am J Alzheimers Dis Other Dement 2007-2008;22:474-488.
21. Mirra SS, Heyman A, McKeel D, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD): part II: standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991;41:479-486.
22. Mackenzie IR, Baker M, Pickering-Brown S, et al. The neuropathology of frontotemporal lobar degeneration caused by mutations in the progranulin gene. Brain 2006; 129:3081-3090. (Pubitemid 44684527)
23. Cairns NJ, Neumann M, Bigio EH, et al. TDP-43 in familial and sporadic frontotemporal lobar degeneration with ubiq-uitin inclusions. Am J Pathol 2007;171:227-240. (Pubitemid 47342406)
24. Davion S, Johnson N, Weintraub S, et al. Clinicopatho-logic correlation in PGRN mutations. Neurology 2007; 69:1113-1121.
25. Geser F, Martinez-Lage M, Robinson J, et al. Clinical and pathological continuum of multisystem TDP-43 pro-teinopathies. Arch Neurol 2009;66:180-189.
26. Whitwell JL, Jack CR Jr, Baker M, et al. Voxel-based mor-phometry in frontotemporal lobar degeneration with ubiquitin-positive inclusions with and without progranu-lin mutations. Arch Neurol 2007;64:371-376. (Pubitemid 46425691)
27. Whitwell JL, Jack CR Jr, Senjem ML, et al. MRI correlates of protein deposition and disease severity in postmortem frontotemporal lobar degeneration. Neurodegener Dis 2009;6:106-117.
28. Josephs KA, Ahmed Z, Katsuse O, et al. Neuropathologic features of frontotemporal lobar degeneration with ubiquitin-positive inclusions with progranulin gene (PGRN) mutations. J Neuropathol Exp Neurol 2007;66: 142-151.
29. Josephs KA, Stroh A, Dugger B, Dickson DW. Evaluation of subcortical pathology and clinical correlations in FTLD-U subtypes. Acta Neuropathol 2009;118:349-358.
30. Armstrong RA, Ellis W, Hamilton RL, et al. Neuropatho-logical heterogeneity in frontotemporal lobar degeneration with TDP-43 proteinopathy: a quantitative study of 94 cases using principal components analysis. J Neural Transm 2010;117:227-239.
31. Hodges JR, Mitchell J, Dawson K, et al. Semantic dementia: demography, familial factors and survival in a consecutive series of 100 cases. Brain 2010;133:300-306.
32. Pereira JM, Williams GB, Acosta-Cabronero J, et al. Atrophy patterns in histologic vs clinical groupings of frontotemporal lobar degeneration. Neurology 2009; 72:1653-1660.
33. Seeley WW, Bauer AM, Miller BL, et al. The natural history of temporal variant frontotemporal dementia. Neurology 2005;64:1384-1390.
34. Brambati SM, Rankin KP, Narvid J, et al. Atrophy progression in semantic dementia with asymmetric temporal involvement: a tensor-based morphometry study. Neuro-biol Aging 2009;30:103-111.